We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: The Gene-Synthesis Revolution
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Technology > The Gene-Synthesis Revolution
The Gene-Synthesis Revolution
Technology

The Gene-Synthesis Revolution

Last updated: November 24, 2021 10:00 am
Editorial Board Published November 24, 2021
Share
SHARE
28Mag Synthesis 1 facebookJumbo

At Ginkgo, the synthesized DNA is then inserted into a host cell, perhaps yeast, which starts producing enzymes and peptides. Trial and error follow. Maybe the outputs from the first gene sequence are too floral, not spicy enough; maybe the ones from the second gene sequence have the right scent, but the cells don’t produce enough of it. Once an effective prototype is found, Ginkgo increases its production by growing the yeast in large vats and streamlining a process for extracting the desired molecules from the soup. What Ginkgo delivers is a recipe and ingredients — the winning genetic code, the host cell and the conditions in which the cells have to be nurtured — which the client can then use on its own.

Ginkgo’s platform first attracted customers in the fragrance industry, but in the last two years it has been partnering with pharmaceutical companies to search for new therapeutics. One such project is seeking to discover the next generation of antibiotics, in order to counter antibiotic resistance. Lucy Foulston, whose background is in molecular microbiology, is leading the effort; Tom Keating, a chemist, is working with her. Together, they highlighted for me a beautiful, twisted paradox — most antibiotics, and most antibiotic resistance, come from bacteria themselves. Bacteria carry genetic snippets with instructions to produce antimicrobial molecules that kill other bacteria. Typically they also have a capacity for self-resistance, so that the bacteria making a particular antibiotic avoid killing themselves, but this resistance can be transferred among bacteria, so that it becomes widespread.

Historically, two paths have been taken to come up with new antibiotics. The first, celebrated in stories of Alexander Fleming and moldy bread, is to seek them in the natural world: Scientists go out, obtain a little bit of soil from a geyser or coral reef, put what they find in a petri dish and see whether it kills any interesting bacteria. The second approach is to comb through chemical libraries in search of molecules that show antibacterial activity. Together, these two approaches gave us a steady supply of new antibiotics up until the 1980s and ’90s, when discoveries began to dry up.

“There was a lot of speculation,” Keating says. “Did we find all the useful ones? Did we find everything that was easy to find? Did we run into bacteria that are now so difficult to kill that the new ones we find don’t really work on them?” Whatever the reason, the reality is that we’ve been running out of new antibiotics in the face of growing antibiotic resistance.

‘I think what we’re just scratching the surface of is, can we program biology to do what chemists have traditionally done.’

The antibiotics project at Ginkgo is looking through bacterial genomes for segments encoded to generate novel antimicrobials. The sequencing efforts of the ’90s and 2000s yielded large databases of bacterial genomes, both public and private, that have given scientists an increasingly sophisticated understanding of which genes produce which molecules. And scientists have also developed the necessary techniques to, as Foulston says, “take these genes out, put them in another bacterial strain” — one they know how to work with — “and then coax that particular strain to produce the molecule of interest.”

Keating continues: “We don’t need the organism anymore. We don’t need it to be growing on a plate. We don’t need it to be killing anything else. All we need is the code.”

You Might Also Like

‘Generative AI helps us bend time’: CrowdStrike, Nvidia embed real-time LLM protection, altering how enterprises safe AI

Meow Wolf and Niantic Spatial discover growth of multimedia artwork with AR

Unreal Editor for Fortnite’s AI character creation software has ambitions past Darth Vader

Databricks open-sources declarative ETL framework powering 90% quicker pipeline builds

Microsoft-backed Mistral launches European AI cloud to compete with AWS and Azure

TAGGED:2021 tech and designAntibioticsBacteriaBiology and BiochemistryBiotechnology and BioengineeringChemistryCrispr (DNA)DNA (Deoxyribonucleic Acid)Genetics and HeredityGinkgo Bioworks IncSynthetic BiologyThe Washington Mail
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Genetic testing shifting into the mainstream, examine finds
Health

Genetic testing shifting into the mainstream, examine finds

Editorial Board December 17, 2024
Carmakers Race to Control Next-Generation Battery Technology
On a regular basis bodily exercise doesn’t sluggish bone loss throughout menopause, finds examine
DePIN Defined: Bringing Actual-World Gadgets to Web3 | NFT Information At this time
Phrases activate hidden mind processes shaping feelings, choices and habits

You Might Also Like

Resident Evil Requiem options terror in first and third-person views
Technology

Resident Evil Requiem options terror in first and third-person views

June 11, 2025
Cubit Studios exhibits off Infinitesimals sci-fi sport with small heroes and large bugs | preview
Technology

Cubit Studios exhibits off Infinitesimals sci-fi sport with small heroes and large bugs | preview

June 11, 2025
Wandercraft raises M for acceleration of AI-powered humanoid robotics and exoskeletons
Technology

Wandercraft raises $75M for acceleration of AI-powered humanoid robotics and exoskeletons

June 11, 2025
Asset sprawl, siloed knowledge and CloudQuery’s seek for unified cloud governance
Technology

Asset sprawl, siloed knowledge and CloudQuery’s seek for unified cloud governance

June 11, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?